Area of research
Molecular Biology · Oncology
Research interest
Research interests include RNA Research and Splicing, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, and Phagocytosis and Immune Regulation.
circCCNY enhances lenvatinib sensitivity and suppresses immune evasion in hepatocellular carcinoma by serving as a scaffold for SMURF1 mediated HSP60 degradation
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy
Time trends in the incidence of interstitial lung disease across Brazil, Russia, India, China and South Africa (<scp>BRICS</scp>) from 1990 to 2019: An age‐period‐cohort analysis
Development and preliminary validation of a PROS scale for Chinese bladder cancer patients with abdominal stoma
Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
Loss of SRSF2 triggers hepatic progenitor cell activation and tumor development in mice
SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing
BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells